Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy - Related Studies

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

This study is ongoing, but not recruiting participants.

Study NCT00004865. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		cetuximab
		cisplatin
		fluorouracil
		paclitaxel

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		Jonsson Comprehensive Cancer Center
		National Cancer Institute (NCI)